Show simple item record

dc.contributor.authorBedell, Susanna E.
dc.contributor.authorGraboys, Thomas B.
dc.contributor.authorDuperval, Melissa
dc.contributor.authorGoldberg, Robert J.
dc.date2022-08-11T08:10:38.000
dc.date.accessioned2022-08-23T17:15:23Z
dc.date.available2022-08-23T17:15:23Z
dc.date.issued2002-04-30
dc.date.submitted2010-05-27
dc.identifier.citationCardiology. 2002;97(2):79-82.
dc.identifier.issn0008-6312 (Linking)
dc.identifier.pmid11978953
dc.identifier.urihttp://hdl.handle.net/20.500.14038/47155
dc.description.abstractSildenafil is a medication increasingly prescribed to improve sexual function in patients who have erectile dysfunction. Because a major contraindication to the use of sildenafil is a history of coronary disease and the concomitant use of nitrates, it becomes increasingly important for cardiologists to prescribe this medication. We evaluated the nature of discussions in all 70 patients for whom sildenafil was prescribed in a cardiology practice between April and July 1998. We used a standardized questionnaire to determine the patients' perspective on the sexual history and the extent to which they wanted their physicians to take a detailed history about sexuality. A separate chart review evaluated the nature of physicians' discussions about sexual functioning before sildenafil was prescribed. Fifty-five of the 70 patients (79%) responded to the survey. The majority of patients (98%) felt that physicians should talk with patients about sexual functioning. However, only 73% of patients believed their doctor was comfortable talking with them about this subject. Sixty percent of patients reported that their doctor had ever talked with them about erectile function and only 15% had ever had a discussion with their doctors about specific difficulties during intercourse. Based on the results of the chart review, only 24% of the patients ever specifically discussed the used of sildenafil with their physician prior to the time that it was prescribed. The results of the study suggest that patients with coronary disease erectile dysfunction are comfortable talking with their physicians about sexual functioning, but these conversations occur infrequently.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=11978953&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1159/000057676
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectCardiovascular Diseases
dc.subjectCoronary Disease
dc.subjectErectile Dysfunction
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPatient Compliance
dc.subjectPhosphodiesterase Inhibitors
dc.subjectPhysician's Practice Patterns
dc.subjectPiperazines
dc.subjectPurines
dc.subjectQuality of Life
dc.subjectQuestionnaires
dc.subjectSexuality
dc.subjectSulfones
dc.subjectBioinformatics
dc.subjectBiostatistics
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.titleSildenafil in the cardiologist's office: patients' attitudes and physicians' practices toward discussions about sexual functioning
dc.typeJournal Article
dc.source.journaltitleCardiology
dc.source.volume97
dc.source.issue2
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/qhs_pp/304
dc.identifier.contextkey1333057
html.description.abstract<p>Sildenafil is a medication increasingly prescribed to improve sexual function in patients who have erectile dysfunction. Because a major contraindication to the use of sildenafil is a history of coronary disease and the concomitant use of nitrates, it becomes increasingly important for cardiologists to prescribe this medication. We evaluated the nature of discussions in all 70 patients for whom sildenafil was prescribed in a cardiology practice between April and July 1998. We used a standardized questionnaire to determine the patients' perspective on the sexual history and the extent to which they wanted their physicians to take a detailed history about sexuality. A separate chart review evaluated the nature of physicians' discussions about sexual functioning before sildenafil was prescribed. Fifty-five of the 70 patients (79%) responded to the survey. The majority of patients (98%) felt that physicians should talk with patients about sexual functioning. However, only 73% of patients believed their doctor was comfortable talking with them about this subject. Sixty percent of patients reported that their doctor had ever talked with them about erectile function and only 15% had ever had a discussion with their doctors about specific difficulties during intercourse. Based on the results of the chart review, only 24% of the patients ever specifically discussed the used of sildenafil with their physician prior to the time that it was prescribed. The results of the study suggest that patients with coronary disease erectile dysfunction are comfortable talking with their physicians about sexual functioning, but these conversations occur infrequently.</p>
dc.identifier.submissionpathqhs_pp/304
dc.contributor.departmentDepartment of Medicine, Division of Cardiovascular Medicine
dc.source.pages79-82


This item appears in the following Collection(s)

Show simple item record